Combination therapy in recent-onset type 1 diabetes

Lancet Diabetes Endocrinol. 2021 Apr;9(4):191-193. doi: 10.1016/S2213-8587(21)00044-9. Epub 2021 Mar 1.

Authors

S Alice Long¹, Cate Speake²

Affiliations

¹ Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101-2795, USA. Electronic address: along@benaroyaresearch.org.
² Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101-2795, USA.

PMID: 33662335
DOI: 10.1016/S2213-8587(21)00044-9

No abstract available

Publication types

Comment

MeSH terms

Adult
Diabetes Mellitus, Type 1* / drug therapy
Double-Blind Method
Humans
Hypoglycemic Agents / therapeutic use
Liraglutide
Metformin*

Substances

Hypoglycemic Agents
Liraglutide
Metformin